Nantahala Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001472322

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2025 · 142 positions · Total reported value $2.00B · Top-10 concentration 34.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 34.3% · 25 new · 19 cut · 13 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.9% · vs SPY -5.1% · Prev Value $2.49B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.3% · vs SPY -4.5% · Latest Value $2.18B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, Nantahala Capital Management, LLC disclosed 142 equity positions with a combined reported value of $2.00B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 34.1% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were EW ($153.45M), TEVA ($78.03M), TBBK ($72.36M). By sector, the heaviest allocations are Health Care 62.5%, Consumer Discretionary 17.4%. Versus the prior quarter, allocation shifted toward Health Care (+13.1pp), Consumer Discretionary (+5.1pp) and away from Other (-20.7pp).

Versus the prior quarter, Nantahala Capital Management, LLC opened 25 new positions, trimmed 19 and fully exited 13, a turnover rate of 34.3% of positions. The portfolio's overlap with the prior quarter was 78% of names.

The largest new positions opened in Q4 2025 were GOGO ($31.65M), CHYM ($15.10M), USNA ($11.49M).

Of the 13 positions fully exited versus the prior quarter, the largest were KRYS ($35.31M), PVLA ($15.68M), HOOD ($14.32M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • GOGO GOGO INC · $31.65M
  • CHYM CHIME FINL INC · $15.10M
  • USNA USANA HEALTH SCIENCES INC · $11.49M
  • BCRX BIOCRYST PHARMACEUTICALS INC · $10.58M
  • PEPG PEPGEN INC · $10.07M
  • GDEN GOLDEN ENTMT INC · $10.01M
  • LXEO LEXEO THERAPEUTICS INC · $9.93M
  • ITGR INTEGER HLDGS CORP · $8.00M

Fully Exited (vs previous quarter)

  • KRYS KRYSTAL BIOTECH INC · prev qtr: $35.31M · history
  • PVLA PALVELLA THERAPEUTICS INC NE · prev qtr: $15.68M
  • HOOD ROBINHOOD MKTS INC · prev qtr: $14.32M
  • DYN DYNE THERAPEUTICS INC · prev qtr: $8.89M
  • RDVT RED VIOLET INC · prev qtr: $8.59M
  • CYTK CYTOKINETICS INC · prev qtr: $8.24M
  • DCTH DELCATH SYS INC · prev qtr: $7.16M
  • VTGN VISTAGEN THERAPEUTICS INC · prev qtr: $7.02M

Insider Transactions (Form 4)

Latest Nantahala Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Nantahala Capital Management, LLC is an SEC-registered 13F filer based in New Canaan, CT, United States. As of Q2 2026 it reported 141 US equity positions with a combined value of $2.49B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW CANAAN, CT, United States
  • SEC registration: 801-72481 (status: Approved), registered 2011-06-24
  • Regulatory AUM (Form ADV): $3.11B as of 2026-09-14
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: nantahalapartners.com

Portfolio Structure

  • 141 positions · $2.49B reported value (Q2 2026)
  • Top 10 holdings = 43.8% of reported value
  • Largest position: IWM (ISHARES TR) at 24.1%
  • Average position size: $17.65M

Sector Tilt

  • Health Care 51.0%
  • Consumer Discretionary 14.7%
  • Financials 2.5%
  • (classified holdings cover 71% of value)

Quarterly Activity

  • Q2 2026: 24 new, 23 added, 38 reduced, 20 exited
  • 56 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 62.5%
Financials 6.1%
Materials 0.7%
Technology 0.5%
Other 10.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.80M $153.45M 7.66%
7.66%
Hold
2 2.50M $78.03M 3.90%
3.90%
Hold
3 1.07M $72.36M 3.61%
3.61%
Add
4 987.69K $71.98M 3.59%
3.59%
Reduce
5 5.00M $62.25M 3.11%
3.11%
Hold
6 68.39M $53.62M 2.68%
2.68%
Hold
7 400.00K $48.77M 2.44%
2.44%
Reduce
8 4.29M $48.56M 2.42%
2.42%
Reduce
9 1.07M $48.11M 2.40%
2.40%
Add
10 6.05M $44.99M 2.25%
2.25%
Add
11 7.34M $44.29M 2.21%
2.21%
Reduce
12 5.82M $38.71M 1.93%
1.93%
Add
13 2.19M $37.44M 1.87%
1.87%
Add
14 5.93M $36.55M 1.82%
1.82%
Add
15 6.79M $31.65M 1.58%
1.58%
New
16 3.57M $31.65M 1.58%
1.58%
Add
17 40.00K $30.87M 1.54%
1.54%
Hold
18 2.45M $30.84M 1.54%
1.54%
Reduce
19 6.85M $30.50M 1.52%
1.52%
Hold
20 117.16K $28.84M 1.44%
1.44%
Reduce
21 754.15K $25.54M 1.27%
1.27%
Add
22 10.85M $23.86M 1.19%
1.19%
Reduce
23 502.00K $23.24M 1.16%
1.16%
Add
24 1.24M $22.43M 1.12%
1.12%
Hold
25 153.24K $20.66M 1.03%
1.03%
Reduce
26 1.18M $19.89M 0.99%
0.99%
Hold
27 224.96K $19.64M 0.98%
0.98%
Reduce
28 5.48M $19.33M 0.96%
0.96%
Add
29 5.06M $19.04M 0.95%
0.95%
Add
30 130.30K $18.57M 0.93%
0.93%
Hold
31 1.22M $18.36M 0.92%
0.92%
Add
32 477.09K $17.63M 0.88%
0.88%
Reduce
33 1.15M $17.10M 0.85%
0.85%
Hold
34 699.30K $16.73M 0.83%
0.83%
Reduce
35 865.99K $16.41M 0.82%
0.82%
Add
36 2.42M $16.36M 0.82%
0.82%
Add
37 644.69K $16.28M 0.81%
0.81%
Hold
38 1.77M $15.88M 0.79%
0.79%
Reduce
39 100.00K $15.62M 0.78%
0.78%
Hold
40 375.00K $15.45M 0.77%
0.77%
Hold
41 600.00K $15.10M 0.75%
0.75%
New
42 675.00K $15.03M 0.75%
0.75%
Hold
43 2.07M $14.45M 0.72%
0.72%
Add
44 1.07M $14.00M 0.70%
0.70%
Hold
45 1.04M $13.99M 0.70%
0.70%
Add
46 3.97M $13.91M 0.69%
0.69%
Add
47 494.97K $13.44M 0.67%
0.67%
Reduce
48 600.00K $13.40M 0.67%
0.67%
Hold
49 3.38M $13.26M 0.66%
0.66%
Hold
50 7.06M $12.99M 0.65%
0.65%
Hold

FAQ

What did Nantahala Capital Management, LLC buy in 2025-Q4?

In its 2025-Q4 13F filing, Nantahala Capital Management, LLC reported 142 equity positions worth $2.00B in aggregate; its largest disclosed positions were EW ($153.45M), TEVA ($78.03M), TBBK ($72.36M).

How large is Nantahala Capital Management, LLC's portfolio?

Nantahala Capital Management, LLC reported $2.00B of long equity holdings across 142 positions as of 2025-Q4. Top-10 holdings account for 34.1% of reported value.

What is Nantahala Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/nantahala-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →